ICON Gestione
Gestione criteri di controllo 4/4
ICON Il CEO è Steve Cutler, nominato in Mar2017, e ha un mandato di 7.67 anni. la retribuzione annua totale è $ 7.24M, composta da 16.4% di stipendio e 83.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.045% delle azioni della società, per un valore di $ 7.90M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 8.3 anni e 7.6 anni.
Informazioni chiave
Steve Cutler
Amministratore delegato
US$7.2m
Compenso totale
| Percentuale dello stipendio del CEO | 16.4% |
| Mandato del CEO | 7.7yrs |
| Proprietà del CEO | 0.04% |
| Durata media del management | 8.3yrs |
| Durata media del Consiglio di amministrazione | 7.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For
Nov 02
Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors
Sep 25Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Sep 09We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt
Aug 25An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued
Aug 10ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
Jul 13Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)
Jun 14Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching
May 30ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet
May 14ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 28What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?
Apr 21ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price
Apr 05ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump
Mar 05With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Feb 07ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
Feb 01These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Jan 23Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jan 08What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E
Dec 24A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Dec 09With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Nov 08Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Oct 09Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Sep 23Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Sep 05Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?
Aug 03Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jun 30Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Jun 12Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
May 23Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Mar 29Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Mar 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?
Feb 21Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Dec 28These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Dec 10Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?
Nov 22Icon selected by BARDA to conduct anthrax vaccine clinical trial
Oct 06Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?
Sep 15ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly
Aug 26Baron Funds - ICON Plc: Positioned For An Extended Period Of Revenue And Earnings Growth
Aug 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?
Aug 01Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$748m |
| Jun 30 2024 | n/a | n/a | US$714m |
| Mar 31 2024 | n/a | n/a | US$683m |
| Dec 31 2023 | US$7m | US$1m | US$612m |
| Sep 30 2023 | n/a | n/a | US$513m |
| Jun 30 2023 | n/a | n/a | US$510m |
| Mar 31 2023 | n/a | n/a | US$510m |
| Dec 31 2022 | US$10m | US$1m | US$505m |
| Sep 30 2022 | n/a | n/a | US$464m |
| Jun 30 2022 | n/a | n/a | US$210m |
| Mar 31 2022 | n/a | n/a | US$168m |
| Dec 31 2021 | US$10m | US$1m | US$153m |
| Sep 30 2021 | n/a | n/a | US$178m |
| Jun 30 2021 | n/a | n/a | US$364m |
| Mar 31 2021 | n/a | n/a | US$338m |
| Dec 31 2020 | US$8m | US$1m | US$328m |
| Sep 30 2020 | n/a | n/a | US$322m |
| Jun 30 2020 | n/a | n/a | US$324m |
| Mar 31 2020 | n/a | n/a | US$368m |
| Dec 31 2019 | US$8m | US$1m | US$369m |
| Sep 30 2019 | n/a | n/a | US$362m |
| Jun 30 2019 | n/a | n/a | US$353m |
| Mar 31 2019 | n/a | n/a | US$333m |
| Dec 31 2018 | US$8m | US$1m | US$323m |
| Sep 30 2018 | n/a | n/a | US$306m |
| Jun 30 2018 | n/a | n/a | US$295m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$7m | US$1m | US$281m |
Compensazione vs Mercato: La retribuzione totale di Steve ($USD 7.24M ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 12.64M ).
Compensazione vs guadagni: La retribuzione di Steve è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Steve Cutler (64 yo)
7.7yrs
Mandato
US$7,244,000
Compensazione
Dr. Steven A. Cutler, also known as Steve, Ph D., MBA, serves as Chairman of Association of Clinical Research Organizations since January 01, 2021. He has been the Chief Executive Officer of ICON Public Li...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 7.7yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | no data | US$290.00k | 0.54% $ 95.7m | |
| Chief Financial Officer | less than a year | Nessun dato | Nessun dato | |
| Senior Vice President of Corporate & Commercial Finance | no data | Nessun dato | Nessun dato | |
| Chief Information Officer | no data | Nessun dato | Nessun dato | |
| Chief Administrative Officer | 15yrs | Nessun dato | 0.0097% $ 1.7m | |
| Director of Corporate Communications | no data | Nessun dato | Nessun dato | |
| Vice President of Marketing | no data | Nessun dato | Nessun dato | |
| Chief Human Resources Officer | 8.3yrs | Nessun dato | Nessun dato | |
| President of Corporate Investments & Partnerships | 2yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Global Clinical Pharmacology | 15.6yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Drug Development Services - CNS | 17.8yrs | Nessun dato | Nessun dato |
8.3yrs
Durata media
53.5yo
Età media
Gestione esperta: Il team dirigenziale di ICLR è esperto e expertise (durata media dell'incarico 8.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 9yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | 14.8yrs | US$290.00k | 0.54% $ 95.7m | |
| Independent Director | 3.3yrs | US$303.00k | 0.0054% $ 943.6k | |
| Independent Non-Executive Director | 7.1yrs | US$323.00k | 0.0026% $ 451.6k | |
| Independent Non-Executive Chairman of the Board | 13.1yrs | US$656.00k | 0.023% $ 4.1m | |
| Lead Independent Director | 8.1yrs | US$359.00k | 0.0026% $ 451.6k | |
| Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 5.3yrs | US$315.00k | 0.0023% $ 411.2k |
7.6yrs
Durata media
64.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ICLR sono considerati esperti (durata media dell'incarico 7.6 anni).